- Investing Ideas
- Australian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Australian Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
5
Value score of at least 4 focused on companies with a low market cap.
5 companies
Trajan Group Holdings
Market Cap: AU$63.3m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.41
7D
1.2%
1Y
-44.7%
Medical Developments International
Market Cap: AU$45.1m
Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.
MVP
AU$0.40
7D
-2.4%
1Y
-16.7%
Botanix Pharmaceuticals
Market Cap: AU$77.6m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.035
7D
-12.5%
1Y
-90.1%
Little Green Pharma
Market Cap: AU$29.7m
Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.
LGP
AU$0.097
7D
0%
1Y
-22.4%
Radiopharm Theranostics
Market Cap: AU$70.9m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.02
7D
-4.8%
1Y
-13.0%